Personalization of prostate cancer prevention and therapy: are clinically qualified biomarkers in the horizon?
{{output}}
Prostate cancer remains the most common malignancy among men and the second leading cause of male cancer-related mortality. Death from this disease is invariably due to resistance to androgen deprivation therapy. Our improved understanding of the biology of p... ...